logo
  

Mirum Pharma Presents Data Showing Impact Of LIVMARLI On Patients With Alagille Syndrome

Mirum Pharmaceuticals, Inc. (MIRM) presented data from clinical programs evaluating
maralixibat in patients with Alagille syndrome. The company said these data further characterize LIVMARLI's clinical potential in pediatric patients including evaluation of its impact on long-term event-free survival. The data were presented at the 54th Annual ESPGHAN Meeting.

LIVMARLI oral solution is an orally administered, once-daily, ileal bile acid transporter inhibitor approved by the FDA for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older.

Pam Vig, head of research and development at Mirum, said: "The years of data that have been generated with maralixibat allow us to look critically at important long-term treatment goals such as growth, transplant rates and predictors of improved outcomes."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Specialty athletic retailer Foot Locker, Inc. reported Friday a second-quarter net profit that plunged from last year, hurt by a sales decline amid markdowns. Quarterly sales met Street estimates. The company also trimmed it adjusted earnings and sales growth guidance for the full-year 2022. Google's hundreds of employees have signed a petition sent to executives demanding extension of abortion care benefits to contract workers. The workers also called to halt donations given to anti-abortion politicians and to expand travel benefits. The petition, circulated by the Alphabet Workers Union, has been signed by over 650 employees at Google's parent company Alphabet Inc. Apple Inc. has released an emergency security update noting that some of its iPhones, iPads and Macs had certain vulnerabilities. The tech major said the flaws potentially allow full admin access to devices. The models affected by the issue include iPhone 6S and later models, several models of the newer iPads, and Mac computers running macOS Monterey and above. The flaws also affect the iPod Touch
Follow RTT